Most of the CPVT1-associated RyR2 mutations cause enhanced Ca2+ release with delayed afterdepolarizations (DADs) and arrhythmias and are considered as gain-of-function mutations. This evidence concerns the gene RYR2 and cardiac arrhythmia.